Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 74, Issue 3

Antimicrobial and antiparasitic potential of lupeol: antifungal effect on the species complex and nematicidal activity against Open Access

Abstract

There is growing concern about infections caused by non- species, including species of the complex – which have seen a considerable increase in cases during the COVID-19 pandemic – in addition to concern about nematode resistance to currently used anthelmintics.

Lupeol is a triterpenoid phytosterol that has a wide range of biological activities, although its antifungal and antiparasitic potential is still poorly explored. Additionally, its effect on the biofilm of the species complex has not yet been studied.

This study aimed to investigate the antifungal effect of lupeol against complex species, in planktonic cells and mature biofilms, as well as its nematicidal potential against . In addition, molecular docking was performed to identify potential target molecules for lupeol’s antifungal effect.

Twelve strains of species complex were used. Planktonic susceptibility was performed through the broth microdilution assay, while the antibiofilm effect was investigated by measuring the biomass and metabolic activity. The antifungal mechanism of action of lupeol was investigated by target fishing. The evaluation of the nematicidal effect was performed using the infection model.

Lupeol demonstrated antifungal activity against planktonic cells with a MIC between 64 and 512 µg ml. In mature biofilms, lupeol was able to reduce biomass starting from a concentration of 1024 µg ml and reduce metabolic activity from a concentration of 64 µg ml. It was observed that there was interaction of lupeol with the enzyme 14α-demethylase. Furthermore, lupeol had a nematicidal effect from a concentration of 64 µg ml.

Lupeol exhibits an antifungal effect on the species complex, in the planktonic and mature biofilm forms, possibly by affecting the ergosterol synthesis. Lupeol further demonstrated a nematicidal potential.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): in vitro , inhibition , nematode , sterol 14α-demethylase , triterpenoid and yeast
© 2025 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. The Microbiology Society waived the open access fees for this article.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001976
2025-03-07
2026-04-18

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/jmm/74/3/jmm001976.html?itemId=/content/journal/jmm/10.1099/jmm.0.001976&mimeType=html&fmt=ahah

References

  1. Denning DW. Global incidence and mortality of severe fungal disease. Lancet Infect Dis 2024; 24:e428–e438 [View Article] [PubMed]
     [Google Scholar]
  2. Lamoth F, Lockhart SR, Berkow EL, Calandra T. Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother 2018; 73:i4–i13 [View Article]
     [Google Scholar]
  3. Vieira JN, Feijó AM, Bueno ME, Gonçalves CL, Lund RG et al. Evaluation of the frequency of Candida spp. in hospitalized and non-hospitalized subjects. Braz J Biol 2018; 78:644–652 [View Article] [PubMed]
     [Google Scholar]
  4. Sun M, Chen C, Xiao W, Chang Y, Liu C et al. Increase in Candida parapsilosis candidemia in cancer patients. Mediterr J Hematol Infect Dis 2019; 11:e2019012 [View Article] [PubMed]
     [Google Scholar]
  5. Kayaaslan B, Eser F, Kaya AK, Bilgic Z, Asilturk D et al. Characteristics of candidemia in COVID-19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non-COVID-19 patients. Mycoses 2021; 64:1083–1091 [View Article] [PubMed]
     [Google Scholar]
  6. Papadimitriou-Olivgeris M, Kolonitsiou F, Kefala S, Spiliopoulou A, Aretha D et al. Increased incidence of candidemia in critically ill patients during the coronavirus disease 2019 (COVID-19) pandemic. Braz J Infect Dis 2022; 26:102353 [View Article] [PubMed]
     [Google Scholar]
  7. Pienthong T, Visuttichaikit S, Apisarnthanarak P, Jantarathaneewat K, Weber DJ et al. Increase in the incidence of Candida parapsilosis and Candida tropicalis bloodstream infections during the coronavirus disease 2019 (COVID-19) pandemic. Antimicrob Steward Healthc Epidemiol 2023; 3:e2 [View Article] [PubMed]
     [Google Scholar]
  8. Won EJ, Sung H, Kim MN. Changing epidemiology of clinical isolates of Candida species during the Coronavirus Disease 2019 pandemic: data analysis from a Korean tertiary care hospital for 6 years (2017-2022). J Fungi 2022; 10:193 [View Article]
     [Google Scholar]
  9. Ramos-Martínez A, Pintos-Pascual I, Guinea J, Gutiérrez-Villanueva A, Gutiérrez-Abreu E et al. Impact of the COVID-19 pandemic on the clinical profile of candidemia and the incidence of fungemia due to fluconazole-resistant Candida parapsilosis. JoF 2022; 8:451 [View Article]
     [Google Scholar]
  10. Routsi C, Meletiadis J, Charitidou E, Gkoufa A, Kokkoris S et al. Epidemiology of candidemia and fluconazole resistance in an ICU before and during the COVID-19 pandemic era. Antibiotics 2022; 11:771 [View Article] [PubMed]
     [Google Scholar]
  11. Trevijano-Contador N, Torres-Cano A, Carballo-González C, Puig-Asensio M, Martín-Gómez MT et al. Global emergence of resistance to fluconazole and voriconazole in Candida parapsilosis in tertiary hospitals in Spain during the COVID-19 pandemic. Open Forum Infect Dis 2022; 9:ofac605 [View Article] [PubMed]
     [Google Scholar]
  12. Cordeiro RA, Sales JA, Ponte YB, Mendes PBL, Serpa R et al. Phenotype-driven strategies for screening Candida parapsilosis complex for molecular identification. Braz J Microbiol 2018; 49 Suppl 1:193–198 [View Article] [PubMed]
     [Google Scholar]
  13. Brilhante RSN, Sales JA, da Silva MLQ, de Oliveira JS, Pereira L de A et al. Antifungal susceptibility and virulence of Candida parapsilosis species complex: an overview of their pathogenic potential. J Med Microbiol 2018; 67:903–914 [View Article] [PubMed]
     [Google Scholar]
  14. Govrins M, Lass-Flörl C. Candida parapsilosis complex in the clinical setting. Nat Rev Microbiol 2024; 22:46–59 [View Article] [PubMed]
     [Google Scholar]
  15. Thakre A, Zore G, Kodgire S, Kazi R, Mulange S et al. Limonene inhibits Candida albicans growth by inducing apoptosis. Med Mycol 2018; 56:565–578 [View Article] [PubMed]
     [Google Scholar]
  16. Fernandes CM, Silva D, Haranahalli K, McCarthy JB, Mallamo J et al. The future of antifungal drug therapy: novel compounds and targets. Antimicrob Agents Chemother 2021; 65:e01719–20 [View Article]
     [Google Scholar]
  17. Branco J, Miranda IM, Rodrigues AG. Candida parapsilosis virulence and antifungal resistance mechanisms: a comprehensive review of key determinants. JoF 2023; 9:80 [View Article]
     [Google Scholar]
  18. Liu K, Zhang X, Xie L, Deng M, Chen H et al. Lupeol and its derivatives as anticancer and anti-inflammatory agents: molecular mechanisms and therapeutic efficacy. Pharmacol Res 2021; 164:105373 [View Article] [PubMed]
     [Google Scholar]
  19. Sharma D, Gupta N. Lupeol: an alternative approach towards cancer treatment.. J Phytopharmacol 2022; 11:425–431 [View Article]
     [Google Scholar]
  20. Singh A, Mukhtar HM, Kaur H, Kaur L. Investigation of antiplasmodial efficacy of lupeol and ursolic acid isolated from Ficus benjamina leaves extract. Natural Product Research 2020; 34:2514–2517 [View Article]
     [Google Scholar]
  21. Nashra DS, Bharadwaj P, Singh H, Das MK. A review on lupeol: beneficial health aspects of potent natural phytosterol and triterpene. J Human Univ 2021; 48:407–423
     [Google Scholar]
  22. Fissiha W, Kinde MZ. Anthelmintic resistance and its mechanism: a review. Infect Drug Resist 2021; 14:5403–5410 [View Article] [PubMed]
     [Google Scholar]
  23. Whittaker JH, Carlson SA, Jones DE, Brewer MT. Molecular mechanisms for anthelmintic resistance in strongyle nematode parasites of veterinary importance. J Vet Pharmacol Ther 2017; 40:105–115 [View Article] [PubMed]
     [Google Scholar]
  24. Potârniche AV, Mickiewicz M, Olah D, Cerbu C, Spînu M et al. First report of anthelmintic resistance in gastrointestinal nematodes in goats in Romania. Animals 2021; 11:2761 [View Article] [PubMed]
     [Google Scholar]
  25. Soares SCP, Reais AC, Castro RLP et al. Resistance of gastrointestinal nematodes of goats and sheep to the antihelmintics levamisole, ivermectin and albendazole. Braz Anim Sci 2023; 24:e–75316 [View Article]
     [Google Scholar]
  26. Martins AC, Bergamasco PLF, Felippelli G, Tebaldi JH, Moraes MFD et al. Haemonchus contortus resistance to monepantel in sheep: fecal egg count reduction tests and randomized controlled trials. Semina Ciênc Agrár 2017; 38:231 [View Article]
     [Google Scholar]
  27. De Hoog GS, Guarro J, Gené J et al. Atlas of clinical fungi, 4th ed. The Netherlands: Centralalbureau voor Schimmelcultures/Universitat Rovira I Virgili Reus; 2008
  28. Tavanti A, Davidson AD, Gow NAR, Maiden MCJ, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol 2005; 43:284–292 [View Article] [PubMed]
     [Google Scholar]
  29. Clinical and Laboratory Standards Institute (CLSI) Reference method for broth dilution antifungal susceptibility testing of yeasts; fourth information supplement. CLSI document M27-A4. Wayne, PA: Clinical and Laboratory Standards Institute; 2017 https://clsi.org/standards/products/microbiology/documents/m27/
  30. Brilhante RSN, Gotay WJP, Pereira VS, de Oliveira JS, Pereira-Neto WA et al. Antifungal activity of promethazine and chlorpromazine against planktonic cells and biofilms of Cryptococcus neoformans/Cryptococcus gattii complex species. Med Mycol 2020; 58:906–912 [View Article] [PubMed]
     [Google Scholar]
  31. Brilhante RSN, Silva JAT, Araújo GDS, Pereira VS, Gotay WJP et al. Darunavir inhibits Cryptococcus neoformans/Cryptococcus gattii species complex growth and increases the susceptibility of biofilms to antifungal drugs. J Med Microbiol 2020; 69:830–837 [View Article] [PubMed]
     [Google Scholar]
  32. Castelo-Branco DSCM, Araújo GS, Fonseca XMQ, de Melo Guedes GM, da Rocha MG et al. Anthraquinones from Aloe spp. inhibit Cryptococcus neoformans sensu stricto: effects against growing and mature biofilms. Biofouling 2021; 37:809–817 [View Article]
     [Google Scholar]
  33. Sayers EW, Bolton EE, Brister JR. Database resources of the national center for biotechnology information. Nucleic Acids Res 2021; 50:D20–6 [View Article]
     [Google Scholar]
  34. Jumper J, Evans R, Pritzel A, Green T, Figurnov M et al. Highly accurate protein structure prediction with AlphaFold. Nature 2021; 596:583–589 [View Article] [PubMed]
     [Google Scholar]
  35. Guedes IA, Silva MM, Galheigo M, Krempser E, de Magalhães CS et al. A free platform for receptor-ligand virtual screening. J Mol Biol 2024; 436:168548 [View Article] [PubMed]
     [Google Scholar]
  36. Brilhante RSN, Oliveira JS de, Evangelista AJ de J, Serpa R, Silva AL da et al. Candida tropicalis from veterinary and human sources shows similar in vitro hemolytic activity, antifungal biofilm susceptibility and pathogenesis against Caenorhabditis elegans. Vet Microbiol 2016; 192:213–219 [View Article] [PubMed]
     [Google Scholar]
  37. Katiki LM, Barbieri AME, Araujo RC, Veríssimo CJ, Louvandini H et al. Synergistic interaction of ten essential oils against Haemonchus contortus in vitro. Vet Parasitol 2017; 243:47–51 [View Article] [PubMed]
     [Google Scholar]
  38. Silva FC, Rodrigues VG, Duarte LP, Lula IS, Sinisterra RD et al. Antidiarrheal activity of extracts from Maytenus gonoclada and inhibition of Dengue virus by lupeol. An Acad Bras Cienc 2017; 89:1555–1564 [View Article] [PubMed]
     [Google Scholar]
  39. Sohag AAM, Hossain MT, Rahaman MA, Rahman P, Hasan MS et al. Molecular pharmacology and therapeutic advances of the pentacyclic triterpene lupeol. Phytomedicine 2022; 99:154012 [View Article] [PubMed]
     [Google Scholar]
  40. Park JS, Rehman IU, Choe K, Ahmad R, Lee HJ et al. A triterpenoid lupeol as an antioxidant and anti-neuroinflammatory agent: impacts on oxidative stress in Alzheimer’s disease. Nutrients 2023; 15:1–19 [View Article] [PubMed]
     [Google Scholar]
  41. Shai LJ, McGaw LJ, Aderogba MA, Mdee LK, Eloff JN. Four pentacyclic triterpenoids with antifungal and antibacterial activity from Curtisia dentata (Burm.f) C.A. Sm. leaves. J Ethnopharmacol 2008; 119:238–244 [View Article] [PubMed]
     [Google Scholar]
  42. Fadipe VO, Mongalo NI, Opoku AR. In vitro evaluation of the comprehensive antimicrobial and antioxidant properties of curtisia dentata (burm.f) C.A. sm: toxicological effect on the human embryonic kidney (HEK293) and human hepatocellular carcinoma (hepg2) cell lines. Exp Clin Sci J 2015; 14:971–983 [View Article]
     [Google Scholar]
  43. Obey JK, Wright AV, Orjala J, Kauhanen J, Tikkanen-Kaukanen C. Antimicrobial activity of Croton macrostachyus stem bark extracts against several human pathogenic bacteria. J Pathog 2016; 2016:1453428 [View Article] [PubMed]
     [Google Scholar]
  44. Siddique HR, Saleem M. Beneficial health effects of lupeol triterpene: a review of preclinical studies. Life Sci 2011; 88:285–293 [View Article] [PubMed]
     [Google Scholar]
  45. Das A, Jawed JJ, Das MC, Sandhu P, De UC et al. Antileishmanial and immunomodulatory activities of lupeol, a triterpene compound isolated from Sterculia villosa. Int J Antimicrob Agents 2017; 50:512–522 [View Article] [PubMed]
     [Google Scholar]
  46. Adnan SNA, Ibrahim N, Yaacob W. Transcriptome analysis of methicillin-resistant Staphylococcus aureus in response to stigmasterol and lupeol. J Glob Antimicrob Resist 2017; 8:48–54 [View Article] [PubMed]
     [Google Scholar]
  47. Manzano PI, Miranda M, AbreuPayrol J, Silva M, Sterner O et al. Pentacyclic triterpenoids with antimicrobial activity from the leaves of Vernonanthura patens (Asteraceae). Emir J Food Agric 2013; 25:539 [View Article]
     [Google Scholar]
  48. Singh B, Singh S. Antimicrobial activity of terpenoids from Trichodesma amplexicaule Roth. Phytother Res 2003; 17:814–816 [View Article] [PubMed]
     [Google Scholar]
  49. Asadzadeh M, Ahmad S, Al-Sweih N, Khan Z. Epidemiology and molecular basis of resistance to fluconazole among clinical Candida parapsilosis isolates in Kuwait. Microb Drug Resist 2017; 23:966–972 [View Article] [PubMed]
     [Google Scholar]
  50. Arastehfar A, Daneshnia F, Najafzadeh MJ, Hagen F, Mahmoudi S et al. Evaluation of molecular epidemiology, clinical characteristics, antifungal susceptibility profiles, and molecular mechanisms of antifungal resistance of Iranian Candida parapsilosis species complex blood isolates. Front Cell Infect Microbiol 2020; 10:206 [View Article] [PubMed]
     [Google Scholar]
  51. Díaz-García J, Machado M, Alcalá L, Reigadas E, Pérez-Ayala A et al. Trends in antifungal resistance in Candida from a multicenter study conducted in Madrid (CANDIMAD study): fluconazole-resistant C. parapsilosis spreading has gained traction in 2022. Antimicrob Agents Chemother 2023; 67:e0098623 [View Article] [PubMed]
     [Google Scholar]
  52. Khalifa HO, Watanabe A, Kamei K. Antifungal resistance and genotyping of clinical Candida parapsilosis complex in Japan. J Fungi 2024; 10:4 [View Article]
     [Google Scholar]
  53. Javed S, Mahmood Z, Khan KM, Sarker SD, Javaid A et al. Lupeol acetate as a potent antifungal compound against opportunistic human and phytopathogenic mold Macrophomina phaseolina. Sci Rep 2021; 11:8417 [View Article] [PubMed]
     [Google Scholar]
  54. Andrade MCL MCL, Oliveira MAS, Santos FAGD, Ximenes Vilela P de B, da Silva MN et al. A new approach by optical coherence tomography for elucidating biofilm formation by emergent Candida species. PLoS One 2017; 12:e0188020 [View Article]
     [Google Scholar]
  55. Hargrove TY, Friggeri L, Wawrzak Z, Qi A, Hoekstra WJ et al. Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis. J Biol Chem 2017; 292:6728–6743 [View Article] [PubMed]
     [Google Scholar]
  56. Alcazar-Fuoli L, Mellado E, Garcia-Effron G, Lopez JF, Grimalt JO et al. Ergosterol biosynthesis pathway in Aspergillus fumigatus. Steroids 2008; 73:339–347 [View Article] [PubMed]
     [Google Scholar]
  57. Elsaman H, Golubtsov E, Brazil S, Ng N, Klugherz I et al. Toxic eburicol accumulation drives the antifungal activity of azoles against Aspergillus fumigatus. Nat Commun 2024; 15:6312 [View Article] [PubMed]
     [Google Scholar]
  58. Monk BC, Sagatova AA, Hosseini P, Ruma YN, Wilson RK et al. Fungal Lanosterol 14α-demethylase: a target for next-generation antifungal design. Biochim Biophys Acta Proteins Proteomics 2020; 1868:140206 [View Article] [PubMed]
     [Google Scholar]
  59. Lee Y, Puumala E, Robbins N, Cowen LE. Antifungal drug resistance: molecular mechanisms in Candida albicans and beyond. Chem Rev 2021; 121:3390–3411 [View Article] [PubMed]
     [Google Scholar]
  60. Li R, Li W, You Y, Guo X, Peng Y et al. Metabolic activation and cytotoxicity of aloe-emodin mediated by sulfotransferases. Chem Res Toxicol 2019; 32:1281–1288 [View Article] [PubMed]
     [Google Scholar]
  61. Sepúlveda‐Crespo D, Reguera RM, Rojo‐Vázquez F, Balaña‐Fouce R, Martínez‐Valladares M. Drug discovery technologies: Caenorhabditis elegans as a model for anthelmintic therapeutics. Med Res Rev 2020; 40:1715–1753 [View Article]
     [Google Scholar]
  62. Geary TG, Thompson DP. Caenorhabditis elegans: how good a model for veterinary parasites?. Vet Parasitol 2001; 101:371–386 [View Article] [PubMed]
     [Google Scholar]
  63. Burns AR, Luciani GM, Musso G. Caenorhabditis elegans is a useful model for anthelmintic discovery. Nat Commun 2015; 24:1–11 [View Article]
     [Google Scholar]
  64. Shai LJ, Bizimenyera ES, Bagla V, McGaw LJ, Eloff JN. Curtisia dentata (Cornaceae) leaf extracts and isolated compounds inhibit motility of parasitic and free-living nematodes. Onderstepoort J Vet Res 2009; 76:249–256 [View Article] [PubMed]
     [Google Scholar]
  65. Abdel-Rahman FH, Alaniz NM, Saleh MA. Nematicidal activity of terpenoids. J Environ Sci Health B 2013; 48:16–22 [View Article] [PubMed]
     [Google Scholar]
  66. Kotsinis V, Dritsoulas A, Ntinokas D, Giannakou IO. Nematicidal effects of four terpenes differ among entomopathogenic nematode species. Agriculture 2023; 13:1143 [View Article]
     [Google Scholar]
  67. Keerthiraj M, Mandal A, Dutta TK, Saha S, Dutta A et al. Nematicidal and molecular docking investigation of essential oils from Pogostemon cablin ecotypes against Meloidogyne incognita. Chem Biodiversity 2021; 18: [View Article]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001976
Loading
Antimicrobial and antiparasitic potential of lupeol: antifungal effect on the Candida parapsilosis species complex and nematicidal activity against Caenorhabditis elegans
J. Med. Microbiol. 74, 001976 (2025); https://doi.org/10.1099/jmm.0.001976
/content/journal/jmm/10.1099/jmm.0.001976
/content/journal/jmm/10.1099/jmm.0.001976
Loading

Data & Media loading...

Supplements

Supplementary material 1

Supplementary material 2

Supplementary material 3

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error